21 May 2020
Tips for running a successful GP business during COVID-19
Telehealth isn’t replacing GP income lost through decreased face-to-face appointments. Waiting rooms are near empty. Patients are scared to return. That’s what we’re hearing from GPs.
There’s a lot of uncertainty around what happens next as the COVID-19 pandemic drags on.
If you want some advice about how to shape your financial fortunes over the next six months, this is the webinar for you.
Who can attend?
GPs, GP owners or practice managers
What will you learn?
- How to protect cash flow
- What to do if you don’t qualify for JobKeeper
- How to cut costs without breaking employment laws
- How to encourage fearful patients to return to your practice
- How to monetise telehealth
- What to ask your accountant
Webinar through Zoom
Presentation and live Q&A with business adviser David Dahm.
Date and Time
Thursday May 28th
- 7:30pm AEST (NSW, VIC, TAS, ACT, QLD)
- 7pm ACDT (SA, NT)
- 5:30pm AWST (WA).
Free (limited capacity – secure your spot by registering now)
David Dahm, GP business adviser, CEO & Founder of Health and Life, Adelaide
David Dahm is a Chartered Accountant and is the CEO and Founder of Health and Life, which is a national Chartered Accounting Firm that provides advisory, tax and accounting services to the healthcare industry. David’s qualifications as a Chartered Accountant include being a Fellow of CPA Australia, a Fellow of the Financial Services Institute of Australia, a Fellow of the Taxation Institute of Australia, a Fellow of the Australian Association of Practice Managers in healthcare, a Certified Practice Manager, Fellow of the Institute of Managers and Leaders, a Fellow of the Governors Leadership Foundation and a Registered Tax Agent and has been an Australian General Practice Surveyor for 10 years. He has also served on various not for profit national and state boards.
Health and Life have serviced over 1,200 clients in Australia, from doctors in general and specialist practice, public and private hospitals, after hour clinics, international pharmaceuticals and the Australian Government, both at State and Federal levels.